How many insider trades does FilingIQ track for FENC?

FilingIQ tracks 463 Form 4 insider transactions for FENC (FENNEC PHARMACEUTICALS INC.), covering filings from Aug 29, 2014 onwards. 45 of those were filed in the last 90 days.

Are FENC insiders net buyers or net sellers?

Across the full Form 4 history for FENC, 185 transactions (40%) were open-market purchases and 116 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FENC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FENC in?

FENNEC PHARMACEUTICALS INC. (FENC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $307.04M.

FENC insider trading

NasdaqCM Healthcare

FENNEC PHARMACEUTICALS INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

463

Last 90 days

Buys / sells

40% / 25%

Market cap

$307.04M

About FENNEC PHARMACEUTICALS INC.

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Company website: fennecpharma.com

FENC insider activity at a glance

FilingIQ has scored 463 insider transactions for FENC since Aug 29, 2014. The most recent filing in our index is dated May 11, 2026.

Across the full history, 185 open-market purchases and 116 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FENC insider trades is 47.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FENC trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for FENC?: FilingIQ tracks 463 Form 4 insider transactions for FENC (FENNEC PHARMACEUTICALS INC.), covering filings from Aug 29, 2014 onwards. 45 of those were filed in the last 90 days.
Are FENC insiders net buyers or net sellers?: Across the full Form 4 history for FENC, 185 transactions (40%) were open-market purchases and 116 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FENC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FENC in?: FENNEC PHARMACEUTICALS INC. (FENC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $307.04M.

Methodology & sources

Every FENC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.